All of kaléo’s products are the combination of a drug, a device utilizing kaléo’s proprietary technology, and a data dossier comparing the product to other available options.
At kaléo, our goal is to develop better therapies for patients. After we have identified a patient population we believe we can positively impact, our pharmaceutical and biopharmaceutical development team evaluates potential drug candidates. Once the drug therapy has been chosen, multiple formulations are tested to select the optimal solution. The team establishes the appropriate development path to ensure success and alignment with kaléo’s regulatory, manufacturing and commercial teams.
From our founding, kaléo has been dedicated to designing products suited to meet the unique needs of each user. This philosophy drives our process and continues to be our priority for every product in our pipeline. And we wouldn’t be able to maintain this approach without having a few important factors in place:
- A robust Human Factors Engineering (HFE) product development approach that puts the patient and other users side by side with our designers and developers.
- Several “families” of key patents.
- A world-class engineering team with a commitment to excellence in innovation.
- A risk-based development program with an emphasis on quality.